Clinical Drug Experience Knowledgebase

abemaciclib (verzenio) (2 trials)

alpelisib (Piqray) (1 trial)

anastrozole (arimidex) (1 trial)

atezolizumab (Tecentriq) (3 trials)

balixafortide (1 trial)

bevacizumab (avastin) (2 trials)

capecitabine (xeloda) (2 trials)

carboplatin (paraplatin) (2 trials)

cb-103 (1 trial)

cobimetinib (cotellic) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

doxorubicin (Doxil) (2 trials)

enzalutamide (xtandi) (1 trial)

eribulin (halaven) (6 trials)

exemestane (aromasin) (1 trial)

fam-trastuzumab deruxtecan-nxki (Enhertu) (3 trials)

Filgrastim (neupogen) (1 trial)

fulvestrant (faslodex) (4 trials)

gdc-0077 (1 trial)

gemcitabine (gemzar) (1 trial)

Giredestrant (2 trials)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

incmga00012 (1 trial)

ipatasertib (3 trials)

ipilimumab (yervoy) (1 trial)

irinotecan (Camptosar) (1 trial)

lenvatinib (lenvima) (1 trial)

letrozole (femara) (4 trials)

loperamide (imodium) (1 trial)

lurbinectedin (Zepzelca) (1 trial)

margetuximab (Margenza) (1 trial)

men1611 (1 trial)

metformin (glucophage) (1 trial)

niraparib (zejula) (2 trials)

nivolumab (opdivo) (1 trial)

olaparib (lynparza) (2 trials)

osimertinib (tagrisso) (1 trial)

paclitaxel (taxol) (5 trials)

palbociclib (ibrance) (3 trials)

patritumab (1 trial)

pembrolizumab (keytruda) (4 trials)

pemetrexed (alimta) (1 trial)

pertuzumab (perjeta) (3 trials)

radium-223 (xofigo) (1 trial)

sacituzumab govitecan (Trodelvy) (1 trial)

talazoparib (talzenna) (1 trial)

tamoxifen (nolvadex) (3 trials)

temsirolimus (torisel) (1 trial)

tocilizumab (actemra) (1 trial)

trastuzumab (herceptin) (4 trials)

tucatinib (Tukysa) (1 trial)